Overall venture funding, as well as “first financing” rounds, fell significantly in the second quarter, reversing 2025’s fast ...

International companies are increasingly inking licensing deals with Chinese biotechs as concerns regarding drug pricing and ...

The chief financial officer and a manager of a failed digital pharmacy company must defend against some federal regulator ...

An AI healthcare platform analyzed 13 years of FDA data to identify companies with highest recall rates and most dangerous ...

A Sun Pharmaceutical plant in India that has been repeatedly cited by the FDA for serious quality control issues failed another inspection last month.

The latest inspection comes 2 1/2 years after the agency allowed Sun Pharma to keep shipping some drugs to Americans even ...

One of the biggest barriers to the adoption of any new biotechnology tool is validation and regulatory clarity.

U.S. inspectors have uncovered new and dangerous breakdowns in drugmaking at an Indian factory owned by Sun Pharma that ...

In the fourth part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line ...